PY Dietrich

451 total citations
13 papers, 380 citations indexed

About

PY Dietrich is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, PY Dietrich has authored 13 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in PY Dietrich's work include Immunotherapy and Immune Responses (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and T-cell and B-cell Immunology (3 papers). PY Dietrich is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and T-cell and B-cell Immunology (3 papers). PY Dietrich collaborates with scholars based in Switzerland, France and South Africa. PY Dietrich's co-authors include J. Bosq, M. Henry‐Amar, J M Cosset, Anne Caignard, Thierry Hercend, Andreas F. Hottinger, JL Pico, Jos Even, Apiradee Lim and Christophe Pannetier and has published in prestigious journals such as Blood, British Journal of Cancer and Annals of Oncology.

In The Last Decade

PY Dietrich

13 papers receiving 371 citations

Peers

PY Dietrich
Craig Soderquist United States
Ashley Plant United States
Jacquelyn J. Roth United States
S. Peters United States
Labib R. Zakka United States
Jasper Rip Netherlands
Craig Soderquist United States
PY Dietrich
Citations per year, relative to PY Dietrich PY Dietrich (= 1×) peers Craig Soderquist

Countries citing papers authored by PY Dietrich

Since Specialization
Citations

This map shows the geographic impact of PY Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PY Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PY Dietrich more than expected).

Fields of papers citing papers by PY Dietrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PY Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PY Dietrich. The network helps show where PY Dietrich may publish in the future.

Co-authorship network of co-authors of PY Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of PY Dietrich. A scholar is included among the top collaborators of PY Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PY Dietrich. PY Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Addeo, Alfredo, et al.. (2018). 192P KRAS as predictive biomarker of response to checkpoint inhibitors in NSCLC. Journal of Thoracic Oncology. 13(4). S114–S115. 1 indexed citations
2.
Dutoit, Valérie, Denis Migliorini, Anna Patrikidou, et al.. (2017). IMA950 multipeptide vaccine adjuvanted with poly-ICLC in combination with standard therapy in newly diagnosed HLA-A2 glioblastoma patients. Annals of Oncology. 28. xi3–xi4. 4 indexed citations
3.
Hottinger, Andreas F., Assma Ben Aïssa, Vittoria Espeli, et al.. (2014). Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. British Journal of Cancer. 110(11). 2655–2661. 58 indexed citations
4.
Loubeyre, Pierre, et al.. (2009). Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital. British Journal of Cancer. 100(11). 1771–1776. 32 indexed citations
5.
Stupp, Roger, Andreas F. Hottinger, Martin J. van den Bent, PY Dietrich, & Alba A. Brandes. (2008). Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers. Annals of Oncology. 19. vii209–vii216. 31 indexed citations
6.
Harrison, Jillian, D. Baetens, Karim Burkhardt, et al.. (2006). Expression and localization of VEGF‐C and VEGFR‐3 in glioblastomas and haemangioblastomas. The Journal of Pathology. 209(1). 34–43. 68 indexed citations
7.
Dietrich, PY, et al.. (2000). Échappement et tolérance des tumeurs à l'apoptose.. médecine/sciences. 16(4). 492–492. 1 indexed citations
8.
Dietrich, PY, Anne Caignard, Apiradee Lim, et al.. (1994). In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84(8). 2815–2820. 11 indexed citations
9.
Dietrich, PY, et al.. (1994). Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?. Blood. 84(4). 1209–1215. 4 indexed citations
10.
Dietrich, PY, et al.. (1994). Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?. Blood. 84(4). 1209–1215. 68 indexed citations
11.
Dietrich, PY, Anne Caignard, Apiradee Lim, et al.. (1994). In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84(8). 2815–2820. 72 indexed citations
12.
Dietrich, PY, Anne Caignard, Anita Diu, et al.. (1992). Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood. 80(9). 2419–2424. 28 indexed citations
13.
Dietrich, PY, Anne Caignard, Anita Diu, et al.. (1992). Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood. 80(9). 2419–2424. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026